$PHIL
PHI GROUP INC Stock $phil

$phil Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-K Financial Statement

#000149315224041102 Filed on October 15, 2024

Income Statement

Concept	2024 Q4	2024 Q2	2024
Revenue			$5.000K
YoY Change			-80.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses			$1.163M
YoY Change			13.37%
Operating Profit			-$1.158M
YoY Change			15.71%
Interest Expense			$400.3K
YoY Change			-57.18%
% of Operating Profit
Other Income/Expense, Net			-$7.038M
YoY Change			52.71%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings			-$8.195M
YoY Change			46.11%
Net Earnings / Revenue			-163907.6%
Basic Earnings Per Share			$0.00
Diluted Earnings Per Share			$0.00
COMMON SHARES
Basic Shares Outstanding	46.87B shares	46.87B shares	44.13B shares
Diluted Shares Outstanding			44.13B shares

Balance Sheet

Concept	2024 Q4	2024 Q2	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents		$303.00
Short-Term Investments
Other Short-Term Assets		$58.33K
YoY Change		-75.84%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets		$58.64K
YoY Change		-77.59%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets		$32.22K
YoY Change		-1.18%
TOTAL ASSETS
Total Short-Term Assets		$58.64K
Total Long-Term Assets		$32.22K
Total Assets		$90.86K
YoY Change		-69.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$626.7K
YoY Change		1.7%
Accrued Expenses		$1.796M
YoY Change		20.91%
Deferred Revenue		$952.7K
YoY Change		-11.71%
Short-Term Debt		$1.919M
YoY Change		64.78%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$9.745M
YoY Change		14.43%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities		$9.745M
Total Long-Term Liabilities
Total Liabilities		$9.745M
YoY Change		14.43%
SHAREHOLDERS EQUITY
Retained Earnings		-$85.51M
YoY Change		10.6%
Common Stock		$75.98M
YoY Change		5.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$44.17K
YoY Change		0.0%
Treasury Stock Shares
Shareholders Equity		-$9.654M
YoY Change
Total Liabilities & Shareholders Equity		$90.86K
YoY Change		-69.12%

Cashflow Statement

Concept	2024 Q4	2024 Q2	2024
OPERATING ACTIVITIES
Net Income			-$8.195M
YoY Change			46.11%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities			-$1.968M
YoY Change			25.14%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$1.868M
YoY Change			21.22%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities			$1.950M
YoY Change			28.21%
NET CHANGE
Cash From Operating Activities			-$1.968M
Cash From Investing Activities
Cash From Financing Activities			$1.950M
Net Change In Cash			-$18.07K
YoY Change			-62.46%
FREE CASH FLOW
Cash From Operating Activities			-$1.968M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92647
CY2024	dei	City Area Code CityAreaCode	714
CY2024	dei	Local Phone Number LocalPhoneNumber	642-0571
CY2024	dei	Security12b Title Security12bTitle	Common Stock
CY2024	dei	Trading Symbol TradingSymbol	PHIL
CY2024	us-gaap	Salaries And Wages SalariesAndWages	210300	usd
CY2023	us-gaap	Salaries And Wages SalariesAndWages	360000	usd
CY2024	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	76791	usd
CY2023	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	95242	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	105093	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	105533	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	1025623	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	409749	usd
CY2024Q1	PHIG	Stock Issued For Stock Purchase Agreements With Current Shareholders StockIssuedForStockPurchaseAgreementsWithCurrentShareholders	707426	usd
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0000704172
CY2024Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent		usd
CY2024	PHIG	Fund In Transit FundInTransit		usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets		usd
CY2024	PHIG	Increase Decrease In Subfund Obligations IncreaseDecreaseInSubfundObligations		usd
CY2024	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities		usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2024Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent		usd
CY2024Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent		usd
CY2024Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity Registrant Name EntityRegistrantName	PHI GROUP, INC.
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WY
CY2024	dei	Entity File Number EntityFileNumber	001-38255-NY
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-0114535
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	17011 Beach Blvd.
CY2024	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 900
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Huntington Beach
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	46873940565	shares
CY2024	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.001
CY2024	dei	Auditor Firm AuditorFirmId	6662
CY2024	dei	Auditor Name AuditorName	M.S. Madhava Rao
CY2024	dei	Auditor Location AuditorLocation	Bengaluru, India
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	303	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19765	usd
CY2023Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	420	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	58333	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	241426	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	58636	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	261611	usd
CY2024Q2	us-gaap	Long Term Investments LongTermInvestments	32220	usd
CY2023Q2	us-gaap	Long Term Investments LongTermInvestments	32604	usd
CY2024Q2	us-gaap	Assets Assets	90856	usd
CY2023Q2	us-gaap	Assets Assets	294215	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	626730	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	616245	usd
CY2024Q2	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	1624775	usd
CY2023Q2	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	1624775	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1795874	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1485310	usd
CY2024Q2	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	4460981	usd
CY2023Q2	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	1164685	usd
CY2024Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	5000	usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	297805	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	278812	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1027782	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	952650	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1079038	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1220576	usd
CY2024Q2	us-gaap	Liabilities Liabilities	9744823	usd
CY2023Q2	us-gaap	Liabilities Liabilities	8516216	usd
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000000	shares
CY2024Q2	us-gaap	Preferred Stock Including Additional Paid In Capital PreferredStockIncludingAdditionalPaidInCapital	2440	usd
CY2023Q2	us-gaap	Preferred Stock Including Additional Paid In Capital PreferredStockIncludingAdditionalPaidInCapital	2440	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	46873940565	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46873940565	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31429380453	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31429380453	shares
CY2024	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 1,500 reverse split
CY2023	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1 for 1,500 reverse split
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	46873941	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	39414493	usd
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	29109985	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	32773102	usd
CY2024Q2	PHIG	Common Stock To Be Issued CommonStockToBeIssued	1890290	usd
CY2023Q2	PHIG	Common Stock To Be Issued CommonStockToBeIssued	22500	usd
CY2024Q2	PHIG	Common Stock To Be Cancelled CommonStockToBeCancelled	35500	usd
CY2023Q2	PHIG	Common Stock To Be Cancelled CommonStockToBeCancelled	35500	usd
CY2024Q2	PHIG	Treasury Stock Common And Preferred Shares TreasuryStockCommonAndPreferredShares	484767	shares
CY2023Q2	PHIG	Treasury Stock Common And Preferred Shares TreasuryStockCommonAndPreferredShares	484767	shares
CY2024Q2	us-gaap	Treasury Stock Value TreasuryStockValue	44170	usd
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	44170	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-85514751	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-77319372	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1936201	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3035495	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-9653967	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-8222002	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	90856	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	294214	usd
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25000	usd
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25000	usd
CY2024	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	770588	usd
CY2023	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	464848	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	1162772	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-1157772	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1000623	usd
CY2024	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	37	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	488	usd
CY2024	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	400303	usd
CY2023	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	934872	usd
CY2024	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	6637341	usd
CY2023	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	3674139	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7037608	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4608523	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-8195380	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-5609146	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44127075436	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34455935655	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44127075436	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34455935655	shares
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-8195380	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-5609146	usd
CY2024	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1491657	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2455157	usd
CY2024	PHIG	Net Change Due To Conversion Of Notes NetChangeDueToConversionOfNotes	-3428526	usd
CY2023	PHIG	Net Change Due To Conversion Of Notes NetChangeDueToConversionOfNotes	-4845007	usd
CY2023	PHIG	Fund In Transit FundInTransit	9500	usd
CY2024	PHIG	Accumulated Other Comprehensive Loss AccumulatedOtherComprehensiveLoss	1612555	usd
CY2024	PHIG	Reserve For Loan ReserveForLoan	-1958703	usd
CY2024	PHIG	Increase Decrease In Marketable Securities IncreaseDecreaseInMarketableSecurities	-420	usd
CY2023	PHIG	Increase Decrease In Marketable Securities IncreaseDecreaseInMarketableSecurities	-126	usd
CY2024	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-241426	usd
CY2023	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-114434	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	58333	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	10485	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	440	usd
CY2023	PHIG	Increase Decrease In Subfund Obligations IncreaseDecreaseInSubfundObligations	50000	usd
CY2024	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	893689	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	553893	usd
CY2024	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-126388	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	413604	usd
CY2023	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	504899	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	777785	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1522836	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1967750	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1572400	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3557	usd
CY2024	PHIG	Proceeds From Financing Loans ProceedsFromFinancingLoans	85619	usd
CY2023	PHIG	Proceeds From Financing Loans ProceedsFromFinancingLoans	49435	usd
CY2024	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	167511	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	29352	usd
CY2024	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1867790	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1540795	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1949682	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1520712	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-18068	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-48131	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17765	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	67896	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	303	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17765	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	6543502	usd
	PHIG	Stock Issued During Value Conversions Of Promissory Notes StockIssuedDuringValueConversionsOfPromissoryNotes	233614	usd
	PHIG	Stock Issued During Value Exercise Of Warrants StockIssuedDuringValueExerciseOfWarrants	2395080	usd
	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-545710	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-6881906	usd
CY2023Q1	PHIG	Stock Issued During Value Conversions Of Promissory Notes StockIssuedDuringValueConversionsOfPromissoryNotes	1576175	usd
CY2023Q1	PHIG	Stock Issued During Value Conversions Of Promissory Notes StockIssuedDuringValueConversionsOfPromissoryNotes	1576175	usd
CY2023Q1	PHIG	Stock Issued During Value Shares Issued For Cash StockIssuedDuringValueSharesIssuedForCash	624865	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	185000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	185000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-8286628	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	974877	usd
CY2023Q2	PHIG	Stock Issued During Value Shares Issued For Cash StockIssuedDuringValueSharesIssuedForCash	919396	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-8222002	usd
CY2023Q3	PHIG	Stock Issued During Value Conversions Of Promissory Notes1 StockIssuedDuringValueConversionsOfPromissoryNotes1	102937	usd
CY2023Q3	PHIG	Stock Issued During Value Exercise Of Warrants1 StockIssuedDuringValueExerciseOfWarrants1	1756320	usd
CY2023Q3	PHIG	Stock Issued During Value Conversions Of Promissory Notes2 StockIssuedDuringValueConversionsOfPromissoryNotes2	75016	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	8540992	usd
CY2023Q4	PHIG	Stock Issued For Stock Purchase Agreements With Current Shareholders StockIssuedForStockPurchaseAgreementsWithCurrentShareholders	296004	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	59500	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-8546330	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-8936654	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-8936654	usd
CY2024Q2	PHIG	Stock Issued During Value Conversions Of Promissory Notes2 StockIssuedDuringValueConversionsOfPromissoryNotes2	289380	usd
CY2024Q2	PHIG	Stock Issued During Value Conversions Of Promissory Notes2 StockIssuedDuringValueConversionsOfPromissoryNotes2	289380	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-9653967	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-9653967	usd
CY2024	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_808_eus-gaap--NatureOfOperations_zKxTRJECeqgj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">NOTE 1</span></b> – <b><span id="xdx_826_zm31ts5u7Gif">NATURE OF BUSINESS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PHI Group, Inc. (n/k/a Philux Global Group Inc) (the “Company” or “PHI”) (<span style="text-decoration: underline">www.philuxglobal.com</span>) is primarily engaged in promoting Philux Global Funds, SCA, SICAV-RAIF, a “Reserved Alternative Investment Fund” (“RAIF”) under the laws of Luxembourg, developing the Asia Diamond Exchange in conjunction with the International Financial Center in Vietnam and advancing a breakthrough “pure” geomagnetic energy technology that may potentially revolutionize the energy industry worldwide. Besides, the Company provides corporate finance services, including merger and acquisition advisory and consulting services for client companies through our wholly owned subsidiaries Philux Capital Advisors, Inc. (www.philuxcapital.com<span style="text-decoration: underline">)</span> and Philux Global Advisors, Inc. and participates in selective industries and special situations aiming to potentially create significant long-term value for our shareholders. Philux Global Funds intends to include a number of sub-funds for investment in select growth opportunities in the areas of renewable energy, real estate, infrastructure, healthcare, agriculture and the Asia Diamond Exchange together with the International Financial Center in Vietnam.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BACKGROUND</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Originally incorporated on June 8, 1982 as JR Consulting, Inc., a Nevada corporation, the Company applied for a Certificate of Domestication and filed Articles of Domestication to become a Wyoming corporation on September 20, 2017. In the beginning, the Company was foremost engaged in mergers and acquisitions and had an operating subsidiary, Diva Entertainment, Inc., which operated two modeling agencies, one in New York and one in California. In January 2000, the Company changed its name to Providential Securities, Inc., a Nevada corporation, following a business combination with Providential Securities, Inc., a California-based financial services company. In February 2000, the Company then changed its name to Providential Holdings, Inc. In October 2000, Providential Securities withdrew its securities brokerage membership and ceased its financial services business. Subsequently, in April 2009, the Company changed its name to PHI Group, Inc. From October 2000 to October 2011, the Company and its subsidiaries were engaged in various transactions in connection with mergers and acquisitions advisory and consulting services, real estate and hospitality development, mining, oil and gas, telecommunications, technology, healthcare, private equity, and special situations. In October 2011, the Company discontinued the operations of Providential Vietnam Ltd., Philand Ranch Limited, a United Kingdom corporation (together with its subsidiaries Philand Ranch - Singapore, Philand Corporation - US, and Philand Vietnam Ltd. - Vietnam), PHI Gold Corporation (formerly PHI Mining Corporation, a Nevada corporation), and PHI Energy Corporation (a Nevada corporation), and mainly focused on acquisition and development opportunities in energy and natural resource businesses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is currently focused on Philux Global Funds, SCA, SICAV-RAIF by launching Philux Global Select Growth Fund and potentially other sub-funds for investment in real estate, renewable energy, infrastructure, agriculture, healthcare and the Asia Diamond Exchange and International Financial Center in Vietnam. In addition, Philux Capital Advisors, Inc. a wholly owned subsidiary of the Company, continues to provide corporate and project finance services, including merger and acquisition (M&A) advisory and consulting services for U.S. and international companies. The Company has also formed Philux Global Advisors, Inc. to serve as the investment advisor to Philux Global Funds and other potential fund clients in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2023, the company signed a business cooperation agreement with SSE Global JSC, a Vietnamese joint stock company, to establish SSE Global Group, Inc., a Wyoming corporation, (<span style="text-decoration: underline">www.sseglobalgroup.com</span>) to commercialize a self-sustainable energy technology.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2023 the Company signed a business cooperation agreement with Saphia Alkali JSC, a Vietnamese joint stock company, to form Sapphire Alkali Global Group in the United States to finance, manufacture, sell and distribute Saphia Alkali’s proprietary products on a worldwide basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2023 the Company signed an Agreement for Comprehensive Cooperation Agreement with a Vietnamese inventor (the “Inventor”) to cooperate in the development and implementation of a proprietary clean energy technology using geomagnetic energy and target the following areas: (1) Applying the Inventor’s proprietary inventions that are specifically designed to exploit the earth’s available geomagnetic energy to generate energy and store energy without using an energy storage system (ESS), (2) Producing and providing generators using the earth’s available geomagnetic energy, (3) Producing engines (spaceships, airplanes, ships, cars, trains, motorcycles, etc.) powered by the earth’s available geomagnetic energy, and (4) Developing additional multiple new technologies that the Inventor has studied and researched. The Parties agree to use Philux Global Energy, Inc., a Wyoming corporation and wholly-owned subsidiary of Philux Global Group, Inc., Registration Number 2022-001066221, incorporated on January 3, 2022, as the operating company to commercialize energy-related products based on the proprietary researches and developments of the Inventor group. The Inventor group has filed a Provisional Patent Application for the Multi-Impulse Energy Technology with the U.S. Patent and Trademark Office (USPTO) and will transfer certain intellectual properties related to energy generation using the earth’s available geomagnetic energy to Philux Global Energy, Inc. for commercialization.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No assurances can be made that the Company will be successful in achieving its plans.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_zIX6AbIMI6Ni" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE OF ESTIMATES</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	420	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-8195380	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-5609146	usd
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44127075436	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34455935655	shares
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44127075436	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34455935655	shares
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2024	us-gaap	Advertising Expense AdvertisingExpense	0	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	500	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1936201	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3035495	usd
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zb4OTzE6rB0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISKS AND UNCERTAINTIES</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the normal course of business, the Company is subject to certain risks and uncertainties. The Company provides its service and receives marketable securities upon execution of transactions. Consequently, the value of the securities received from customers can be affected by economic fluctuations and each customer’s business growth. The actual realized value of these securities could be significantly different than recorded value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	420	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	626730	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	616245	usd
CY2024Q2	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	1624775	usd
CY2023Q2	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	1624775	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1795874	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1485310	usd
CY2024Q2	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	4460981	usd
CY2023Q2	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	1164685	usd
CY2024Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	5000	usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	297805	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	952650	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1079038	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1220576	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	9744823	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	8516216	usd
CY2024Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1238095	usd
CY2024Q2	us-gaap	Interest Payable Current InterestPayableCurrent	543834	usd
CY2024Q2	PHIG	Accrued Financing Costs AccruedFinancingCosts	10000	usd
CY2024Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	1919153	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	952650	usd
CY2023	PHIG	Ownership Percentage Of Subfund Participants OwnershipPercentageOfSubfundParticipants	0.49	pure
CY2024Q2	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	1624775	usd
CY2024Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	5000	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000000	shares
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Treasury Stock Value TreasuryStockValue	44170	usd
CY2023Q2	us-gaap	Shares Outstanding SharesOutstanding	39414493275	shares
CY2024Q2	us-gaap	Shares Outstanding SharesOutstanding	46873940565	shares
CY2015Q1	us-gaap	Employee Stock Ownership Plan Esop Number Of Allocated Shares EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares	1000000	shares
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0118	pure
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.393	pure
CY2024	us-gaap	Interest Expense InterestExpense	400303	usd
CY2024	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	37	usd
CY2024	us-gaap	Other Expenses OtherExpenses	6637341	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7037608	usd
CY2024Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	85514751	usd
CY2024	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	The net operating loss carry forward may be used to reduce taxable income through the year 2037. Net operating loss for carry forwards for the State of California is generally available to reduce taxable income through the year 2027. The availability of the Company’s net operating loss carry-forward is subject to limitation if there is a 50% or more positive change in the ownership of the Company’s stock.
CY2024Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25000000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-85514751	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-9653967	usd
CY2024	PHIG	No Insider Trading Flag NoInsiderTradingFlag	true

Files In Submission

Name	View Source	Status
0001493152-24-041102-index-headers.html	Edgar Link	pending
0001493152-24-041102-index.html	Edgar Link	pending
0001493152-24-041102.txt	Edgar Link	pending
0001493152-24-041102-xbrl.zip	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fin_001.jpg	Edgar Link	pending
form10-k.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
phig-20240630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
phig-20240630_lab.xml	Edgar Link	unprocessable
phig-20240630_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
phig-20240630_cal.xml	Edgar Link	unprocessable
phig-20240630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PHIL
PHI GROUP INC Stock $phil

2024 Q4 Form 10-K Financial Statement

#000149315224041102 Filed on October 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PHIL PHI GROUP INC Stock $phil

2024 Q4 Form 10-K Financial Statement

#000149315224041102 Filed on October 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PHIL
PHI GROUP INC Stock $phil